UFP Technologies, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
UFP Technologies, Inc. (UFPT) reported Cash and Cash Equivalents, Period Increase (Decrease) of $3.59 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-08
- UFP Technologies, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was $3.59M.
- UFP Technologies, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was -$7.65M.
- UFP Technologies, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $6.16M.
- UFP Technologies, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $2.74M.
- UFP Technologies, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $505.00K.
- UFP Technologies, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$34.74M, a 624.85% decline from fiscal 2017.
- UFP Technologies, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $6.62M, a 325.66% increase from fiscal 2016.
- UFP Technologies, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $1.55M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2020-03-31 | $3.59M 10-Q · filed 2020-05-08 | -$4.06M derived: sum of 2 quarters · filed 2020-05-08 | $2.10M derived: sum of 3 quarters · filed 2020-05-08 | $4.84M derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | -$7.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$1.49M derived: sum of 2 quarters · filed 2020-03-13 | $1.25M derived: sum of 3 quarters · filed 2020-03-13 | $505.00K 10-K · filed 2020-03-13 |
| 2019-09-30 | $6.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $8.90M derived: sum of 2 quarters · filed 2019-11-08 | $8.15M 10-Q · filed 2019-11-08 | $6.30M derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-06-30 | $2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.99M 10-Q · filed 2019-08-09 | $143.00K derived: sum of 3 quarters · filed 2020-05-08 | -$684.00K derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-03-31 | -$745.00K 10-Q · filed 2020-05-08 | -$2.60M derived: sum of 2 quarters · filed 2020-05-08 | -$3.42M derived: sum of 3 quarters · filed 2020-05-08 | -$4.57M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$2.68M derived: sum of 2 quarters · filed 2020-03-13 | -$3.83M derived: sum of 3 quarters · filed 2020-03-13 | -$34.74M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$827.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$1.98M derived: sum of 2 quarters · filed 2019-11-08 | -$32.89M 10-Q · filed 2019-11-08 | -$32.16M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | -$1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$32.06M 10-Q · filed 2019-08-09 | -$31.33M derived: sum of 3 quarters · filed 2020-03-13 | -$28.60M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | -$30.91M 10-Q · filed 2019-05-10 | -$30.18M derived: sum of 2 quarters · filed 2020-03-13 | -$27.45M derived: sum of 3 quarters · filed 2020-03-13 | -$26.69M derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $732.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $3.46M derived: sum of 2 quarters · filed 2020-03-13 | $4.22M derived: sum of 3 quarters · filed 2020-03-13 | $6.62M 10-K · filed 2020-03-13 |
| 2017-09-30 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $3.49M derived: sum of 2 quarters · filed 2018-11-09 | $5.89M 10-Q · filed 2018-11-09 | $7.13M derived: sum of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | $759.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $3.15M 10-Q · filed 2018-08-09 | $4.40M derived: sum of 3 quarters · filed 2019-03-15 | |
| 2017-03-31 | $2.40M 10-Q · filed 2018-05-10 | $3.64M derived: sum of 2 quarters · filed 2019-03-15 | ||
| 2016-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $1.55M 10-K · filed 2019-03-15 | ||
| 2016-09-30 | $314.00K 10-Q · filed 2017-11-09 | |||
| 2015-12-31 | -$4.25M 10-K · filed 2018-03-16 | |||
| 2011-06-30 | $3.68M 10-Q · filed 2011-08-10 | |||
| 2010-06-30 | $4.24M 10-Q · filed 2011-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |